Innovation through science
Founded on the belief that scientific advances must be transformed into practical, indisputable solutions for healthcare professionals and patients, we combine the rigour of fundamental research with operational excellence.
Our approach
Our multicentre studies, conducted in collaboration with leading medical centres in France and abroad,
prove the effectiveness of our salivary RNA signatures in diagnosing endometriosis and other conditions with unmatched accuracy.
This breakthrough stems from the synergy of next-generation sequencing (NGS) and artificial intelligence (AI), marking a key step in improving women’s quality of life.
Innovation and accessibility at the core of our approach
Our technology is not only cutting-edge but also designed to make diagnosis more accessible. Using a simple saliva sample, our test offers a non-invasive and easily performed alternative, independent of the quality of the operator, in stark contrast to current diagnostic methods.
This approach places science in the service of patient well-being, facilitating early diagnosis and shortening treatment times.
Towards a future of personalised care
The pursuit of our mission does not stop at diagnosis. The implications of our salivary RNA research open up promising avenues for the development of targeted therapies, personalised to the specific needs of each patient. At Ziwig, we are convinced that the future of medicine lies in personalised care, and we are dedicated to turning this vision into reality.
Stay connected
Sign up to be notified of the latest news and publications.
